Reduction in Pruritus Across Indications in Phase 3 Trials of Topical Roflumilast in Patients as Young as 2 Years. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 Apr. 30];10(2):s766. Available from: https://skin.dermsquared.com/skin/article/view/4064